Academic Medical Center at the University of Amsterdam — Clinical Trial Site

14 Registered trials

4 Currently recruiting

Organisation

Academic Medical Center at the University of Amsterdam

Location

Amsterdam, Netherlands

Identifier

ORG-100050952

Address

Meibergdreef 9, 1105 AZ, Netherlands

Departments

Cardiology
Department of Vascular Medicine
Dept Hematology
Dept. of Nephrology, D3-230
Endocrinologie
Gynaecology
Hematology
Internal medicine
Medical Oncology
Oncology
Radiotherapy
Surgery

Clinical trials at this site (14)

Search interface

T3-4-Hypo trial Recruiting

2024-513883-24-00 Hypothyroidism Triiodothyronine Quality of Life Persist 5 2025-11-02
Master protocol of TCR-modified T cell therapy targeting HLA-restricted KRAS antigen administered in adult patients with metastatic or local… Recruiting

2024-513900-32-00 Pancreatic Ductal Adenocarcinoma 7 2025-07-03
Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n… Recruiting

2023-504637-42-01 aortic valve stenosis 6 2023-12-21
Multicentre, open-label, randomized, controlled, parallel arms clinical trial of induction chemotherapy followed by chemoradiotherapy versus… Recruiting

2024-512526-28-00 Locally recurrent rectal cancer 5 2020-10-28
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer Ended

2024-512998-27-00 Non-Small Cell Lung Cancer 5 2025-02-21
Comparison of targeted radiotherapy with and without short-term hormonal treatment (6 months) Ended

2024-511252-41-00 Patients with biochemical recurrence after primary trea 5 2024-07-30
A Study to Evaluate NTLA-2002 in adults with Hereditary Angioedema (HAE) Ended

2024-512317-40-00 Hereditary Angioedema 9 2022-04-13
Phase 3 Study of Anifrolumab in Adult Patients with Active Proliferative Lupus Nephritis Ended

2023-506359-68-00 Active Proliferative Lupus Nephritis 5 2022-04-08
A Study to Evaluate the Efficacy and Safety of Crovalimab versus Eculizumab in Adult and Adolescent Patients with Paroxysmal Nocturnal Hemog… Ended

2023-506498-36-00 Paroxysmal Nocturnal Hemoglobinuria (PNH) 5 2021-04-08
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial) Ended

2024-515398-90-01 Staphylococcus aureus bacteremia 5 2020-08-17
WOMEN&More: Efficacy, safety, and acceptability of mifepristone 50 mg once-weekly as a contraceptive Ended

2022-502694-41-00 Contraception 5 2025-04-14
Routine versus selective protamine administration to reduce bleeding complications after transcatheter aortic valve implantation Ended

2023-504205-36-00 Aortic stenosis 11 2023-11-01
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Oc… Ended

2022-502542-28-00 Sickle Cell Disease 4 2021-12-06
LAVA1207-001/LAVA1207-002 A Phase 1 and 2a open-label trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immun… Ended

2024-515821-27-00 Prostate Cancer 9 2021-11-30